Harvard Bioscience Inc expected to post earnings of 3  cents a share - Earnings Preview

Harvard Bioscience

04/05/2021 15:13

* Harvard Bioscience Inc  HBIO.OQ   HBIO.O  is expected to show
a rise in quarterly revenue when it reports results on May 6.
* The Holliston, Massachusetts-based company is expected to
report  a 8.2% increase in revenue to $25.73 million from $23.77
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for Harvard Bioscience Inc
is for earnings of 3 cents per share. For the same quarter last
year, the company reported a loss of 1 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had fallen by
about 11.4% in the last three months.​
* Wall Street's median 12-month price target for Harvard
Bioscience Inc is $9​, about 22.4% above​ its last closing price
of $6.98. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020              0.07       0.08      Beat    23.1
 Sep. 30 2020  0.03        0.04       0.04      Met     14.3
 Jun. 30 2020  -0.01       -0.01      0.05      Beat    600​
 Mar. 31 2020  0.03        0.03       -0.01     Missed  -130
 Dec.          0.09​       0.09       0.08      Missed  -7.7​
 31​ 2019​                                              
 Sep. 30 2019  0.06        0.05       0.04      Missed  -25​
 Jun. 30 2019  0.04        0.04       0.04      Met     0
 Mar. 31 2019  0.03        0.03       0.02      Missed  -40
 This summary was machine generated May 4 at 14:13 GMT.  All
figures in US dollars unless otherwise stated